LISATA THERAPEUTICS, INC. — Director's Dealing 2012

Apr 16, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2012-04-13

Reporting Person: Smith Robin L (Director, Chairman of the Board and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-04-13	Common stock, $0.001 par value	A	26313	$0.33	Acquired	1484681	Direct

Footnotes

F1: On January 31, 2012, the Compensation Committee of the Issuer's Board of Directors approved an arrangement whereby the Reporting Person shall receive, at her option, her net pay for the pay period ending January 31, 2012 through the pay period ending July 31, 2012 through the issuance to her by the Issuer of shares of the Issuer's common stock at the then-market price, under and subject to the terms and conditions of the Issuer's 2009 Equity Compensation Plan (the "2009 Plan").